Note: See Chapter 206, Laws of 1981 section 47.
History: Cr. Register, October, 1973, No. 214, eff. 11-1-73.
CSB 2.04 Addition of amobarbital, pentobarbital, and secobarbital to schedule II; retention of certain forms of amobarbital, pentobarbital and secobarbital in schedule III. (1) Subsection (7) of s. 161.16, Stats., schedule II is hereby created to read as follows:
(7) Unless excepted under federal regulations or listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:
(a) Amobarbital
(b) Pentobarbital
(c) Secobarbital
(2) Paragraphs (m) and (n) of sub. (3), s. 161.18, Stats., schedule III, are hereby created to read as follows:
(m) Unless excepted under federal regulations, any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.
(n) Unless excepted under federal regulations, any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or any salt of any of these drugs and approved by the federal food and drug administration for marketing only as a suppository.
Note: See Chapter 206, Laws of 1981 sections 30 and 37.
History: Cr. Register, July, 1974, No. 223, eff. 8-1-74.
CSB 2.05 Addition of drotebanol to schedule I. The substance known as drotebanol is hereby added to s. 161.14, Stats., schedule I in sub. (3), par. (hm), which paragraph is created to read:
(hm) Drotebanol;
History: Cr. Register, July, 1974, No. 223, eff. 8-1-74.
CSB 2.06 Addition of pentazocine to schedule III. Subsection (4m) of s. 161.18, Stats., schedule III is hereby created to read as follows:
(4m) Pentazocine.
Note: See Chapter 6, Laws of 1981 sections 2 and 3.
History: Cr. Register, August, 1974, No. 224, eff. 9-1-74.
CSB 2.07 Transfer of hydrochloride form of etorphine from schedule I to schedule II. (1) Subsection (3) (intro.) of s. 161.14, Stats., schedule I is amended to read:
(3) Unless specifically excepted or listed in another schedule, any of the following opium derivatives, their salts, isomers and salts of isomers whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:
(2) Paragraph (em) of sub. (3), s. 161.16, Stats., schedule II, is hereby created to read:
(em) Etorphine hydrochloride;
Note: See Chapter 206, Laws of 1981 sections 6, 20 and 24.
History: Cr. Register, August, 1974, No. 224, eff. 9-1-74.
CSB 2.08 Addition of poppy straw to schedule II, addition of pemoline and mebutamate to schedule IV. (1) Paragraph (d) of sub. (2), s. 161.16, Stats., schedule II is hereby created to read:
(d) Concentrate of poppy straw (the crude extract of Poppy Straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy).
(2) Paragraph (n) of sub. (2) of s. 161.20, Stats., schedule IV is hereby created to read:
(n) Mebutamate
(3) Paragraph (b) of sub. (2m) of s. 161.20, Stats., schedule IV is hereby created to read:
(b) Pemoline:
Note: See Chapter 206, Laws of 1981 sections 20, 22 and 45.
History: Cr. Register, February, 1976, No. 242, eff. 3-1-76.
CSB 2.09 Additions to schedules IV and I. (1) Addition of benzodiazepine substances to schedule IV. Paragraphs (cm), (cn), (cp), (cr), (em) and (hm) of sub. (2), s. 161.20, Stats., schedule IV are hereby created to read:
(cm) Chlordiazepoxide
(cn) Clonazepam
(cp) Chlorazepate
(cr) Diazepam
(em) Flurazepam
(hm) Oxazepam
(2) Addition of the thiophene analog of phencyclidine to schedule I. Paragraph (u) of sub. (4), s. 161.14, Stats., schedule I is hereby created to read:
(u) Thiophene analog of phencyclidine
(3) Addition of mecloqualone to schedule I. Subsection (5) and par. (a) of s. 161.14, Stats., schedule I are hereby created to read:
(5) Depressants. Unless specifically excepted or unless listed in another schedule, any material compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:
(a) Mecloqualone
(4) Addition of difenoxin to schedule I. Paragraph (hg) of sub. (2), s. 161.14, Stats., schedule I is hereby created to read:
(hg) Difenoxin
(5) Addition of 2,5 dimethoxyamphetamine, 4-romo-2,5 dimethoxyamphetamine and 4-methoxyamphetamine to schedule I. Paragraphs (v), (w) and (x) of sub. (4), s. 161.14, Stats., schedule I are hereby created to read:
(v) 2,5-dimethoxyamphetamine
(w) 4-bromo-2,5-dimethoxyamphetamine
(x) 4-methoxyamphetamine
Note: See Chapter 206, Laws of 1981 sections 13 and 15.
History: Cr. Register, April, 1976, No. 244, eff. 5-1-76.
CSB 2.10 Addition of propiram to schedule I. Paragraph (wn) of sub. (2), s. 161.14, Stats., schedule I is hereby created to read:
(wn) Propiram
History: Cr. Register, August, 1976, No. 248, eff. 9-1-76.
CSB 2.11 Renumbering and addition to schedule IV of diethylpropion and phentermine. Paragraph (a) of sub. (2m), s. 161.20, Stats., schedule IV is hereby renumbered to read:
(b) Fenfluramine
Paragraph (a) of sub. (2m), s. 161.20, Stats., schedule IV is hereby created to read:
(a) Diethylpropion
Paragraph (b) of sub. (2m), s. 161.20, Stats., schedule IV is hereby renumbered to read:
(c) Pemoline
Paragraph (d) of sub. (2m), s. 161.20, Stats., schedule IV is hereby created to read:
(d) Phentermine
History: Cr. Register, August, 1976, No. 248, eff. 9-1-76.
CSB 2.13 Addition of dextropropoxyphene to schedule IV. Subsection (4), s. 161.20, Stats., schedule IV is hereby created to read:
(4) Other substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts:
(a) Dextropropoxyphene (Alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane)
Note: See Chapter 206, Laws of 1981 section 51.
History: Cr. Register, November, 1977, No. 263, eff. 12-1-77.
CSB 2.14 Addition of prazepam to schedule IV. Paragraph (km), sub. (2), s. 161.20, Stats., schedule IV is hereby created to read:
(km) Prazepam
History: Cr. Register, November, 1977, No. 263, eff. 12-1-77.
CSB 2.15 Addition of parahexyl to schedule I; removal of loperamide from schedule V; addition of triazolam to schedule IV. (1) Paragraph (mn) of sub. (4), s. 161.14, Stats., is created to read:
(mn) Parahexyl
(2) Paragraph (a) of sub. (3), s. 161.22, Stats., is repealed.
(3) Paragraph (nm) of sub. (2), s. 161.20, Stats., is created to read:
(nm) Triazolam
History: Cr. Register, October, 1984, No. 346, eff. 11-1-84.
CSB 2.16 Transfer of sufentanil from schedule I to schedule II. (1) Section 161.14 (2) (xg), Stats., is repealed.
(2) Section 161.16 (3) (y), Stats., is created to read:
(y) Sufentanil
History: Cr. Register, October, 1984, No. 346, eff. 11-1-84.
CSB 2.17 Addition of buprenorphine to schedule V; transfer of methaqualone from schedule II to schedule I; transfer of dronabinol from schedule I to schedule II. (2) Paragraph (b) of s. 161.14 (5), Stats., is adopted to read:
(b) Methaqualone
(3) Subsection (7) (am) of s. 161.16, Stats., is repealed.
(4) Subsection (10) (a) of s. 161.16, Stats., is created to read:
(10) Hallucinogenic substances. (a) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. food and drug administration approved drug product. (Other names for dronabinol are (6a R - trans) - 6a, 7, 8, 10a - tetrahydro - 6, 6, 9 - trimethyl - 3 -pentyl-6H-dibenzo (b, d) pyran - 1 - ol, or (-) - delta - 9 - (trans) - tetrahydrocannabinol.)
History: Cr. Register, August, 1986, No. 368, eff. 9-1-86; CR 03-056: r. (1) Register January 2004 No. 577, eff. 2-1-04.
Loading...
Loading...
Published under s. 35.93, Stats. Updated on the first day of each month. Entire code is always current. The Register date on each page is the date the chapter was last published.